Chronic treatment regimen using glucagon-like insulinotropic peptides
US7259233B2 · kind B2 · utility
140Cited by
8References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2001 |
| Grant date | Aug 21, 2007 |
| Priority date | — |
| Expiry date | Sep 17, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.